From Casetext: Smarter Legal Research

BAYER SCHERING PHARMA AG v. LUPIN LD. LUPIN PHAR

United States District Court, D. Nevada
Nov 17, 2010
2:10-cv-1166-GMN-RJJ (D. Nev. Nov. 17, 2010)

Opinion

2:10-cv-1166-GMN-RJJ.

November 17, 2010


ORDER


This matter is before the undersigned Magistrate Judge on the Re-Filing of Stipulated Consolidated Joint Discovery Plan and Scheduling Order (#28) and Corrected Re-Filing of Stipulated Consolidated Joint Discovery Plan and Scheduling Order (#29).

The Court having reviewed the Re-Filing (#28) and Corrected Re-Filing (#29) and good cause appearing therefore,

IT IS HEREBY ORDERED that the Corrected Re-Filing of Stipulated Consolidated Joint Discovery Plan and Scheduling Order (#29) is GRANTED. Further, the Court adopts the Stipulated Consolidated Joint Discovery Plan and Scheduling Order attached as Exhibit 1 to the Corrected Re-Filing (#29).

IT IS FURTHER ORDERED that the Re-Filing (#28) is MOOT based on the Corrected Re-Filing (#29).

DATED this 17th day of November, 2010.


Summaries of

BAYER SCHERING PHARMA AG v. LUPIN LD. LUPIN PHAR

United States District Court, D. Nevada
Nov 17, 2010
2:10-cv-1166-GMN-RJJ (D. Nev. Nov. 17, 2010)
Case details for

BAYER SCHERING PHARMA AG v. LUPIN LD. LUPIN PHAR

Case Details

Full title:BAYER SCHERING PHARMA AG BAYER HEALTHCARE PHARMACEUTICALS INC., Plaintiff…

Court:United States District Court, D. Nevada

Date published: Nov 17, 2010

Citations

2:10-cv-1166-GMN-RJJ (D. Nev. Nov. 17, 2010)